ECOG-ACRIN Cancer Research Group is a leading brand in biomarker-driven medical research for adults with or at risk of developing cancer. With a network of nearly 1,300 academic and community-based cancer centers worldwide, ECOG-ACRIN conducts clinical trials and provides advanced cancer treatments and outcomes research. Their research programs cover a wide range of scientific disciplines, including therapeutic studies, biomarker sciences, cancer control and outcomes, and imaging core lab services.

In addition, they offer research support committees, resources for active clinical trials, and training and education opportunities. ECOG-ACRIN's mission is to improve the lives of adults affected by cancer through precision oncology, immunotherapy, and reducing over-treatment and over-diagnosis. They strive to inform therapeutic decision-making through novel biomarker platforms and advance standards of care for diverse populations.

With over 55 active clinical trials and 13,000 individual members, ECOG-ACRIN is a globally recognized organization within the National Cancer Institute's National Clinical Trials Network. Join them in their pursuit of groundbreaking research and advancements in cancer care